European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)

Table 1 General Screening Concepts

	Benefit	No Benefit
No Harm	Screening and treatment help. No side effects or harm	Screening and treatment do not help. No side effects or harm
Harm	Screening and treatment help, but side effects or harm	Screening and treatment do not help, but side effects or harm

ISSN: 1750-1172